Since their first description in 1988, glycopeptide-resistant enterococci (GRE) have emerged as a significant cause of nosocomial infections and colonisations, particularly in Europe and the USA. Two major genetically distinct forms of acquired resistance, designated VanA and VanB, are recognised, although intrinsic resistance occurs in some enterococcal species (VanC) and a third form of acquired resistance (VanD) has been reported recently. The biochemical basis of each resistance mechanism is similar; the resistant enterococci produce modified peptidoglycan precursors that show decreased binding affinity for glycopeptide antibiotics. Although VanA resistance is detected readily in the clinical laboratory, the variable levels of vancomycin resistance associated with the other phenotypes makes detection less reliable. Under-reporting of VanB resistance as a result of a lower detection rate may account, in part, for the difference in the numbers of enterococci displaying VanA and VanB resistance referred to the PHLS Laboratory of Hospital Infection. Since 1987, GRE have been referred from >1100 patients in almost 100 hospitals, but 88% of these isolates displayed the VanA phenotype. It is possible that, in addition to the problems of detection, there may be a real difference in the prevalence of VanA and VanB resistance reflecting different epidemiologies. Our present understanding of the genetic and biochemical basis of these acquired forms of glycopeptide resistance has been gained mainly in the last 5 years. However, these relatively new enterococcal resistances appear still to be evolving; there have now been reports of transferable VanB resistance associated with either large chromosomally borne transposons or plasmids, genetic linkage of glycopeptide resistance and genes conferring high-level resistance to aminoglycoside antibiotics, epidemic strains of glycopeptide-resistant Enterococcus faecium isolated from multiple patients in numerous hospitals, and of glycopeptide dependence (mutant enterococci that actually require these agents for growth). The gene clusters responsible for VanA and VanB resistance are located on transposable elements, and both transposition and plasmid transfer have resulted in the dissemination of these resistance genes into diverse strains of several species of enterococci. Despite extensive research, knowledge of the origins of these resistances remains poor. There is little homology between the resistance genes and DNA from either intrinsically resistant gram-positive genera or from the soil bacteria that produce glycopeptides, which argues against direct transfer to enterococci from these sources. However, recent data suggest a more distant, evolutionary relationship with genes found in glycopeptide-producing bacteria. In Europe, VanA resistance occurs in enterococci isolated in the community, from sewage, animal faeces and raw meat. This reservoir suggests that VanA may not have evolved in hospitals, and its existence has been attributed, controversially, to use of the glycopeptide avoparcin as a growth promoter, especially in pigs and poultry. However, as avoparcin has never been licensed for use in the USA and, to date, VanB resistance has not been confirmed in non-human enterococci, it is clear that the epidemiology of acquired glycopeptide resistance in enterococci is complex, with many factors contributing to its evolution and global dissemination.
LeclercqR.,
DerlotE.,
DuvalJ.,
CourvalinP. Strains of Enterococcus faecium highly resistant to vancomycin and teicoplanin. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1987; 275: Abstract 1023
LeclercqR.,
DerlotE.,
DuvalJ.,
CourvalinP. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med1988; 319:157–161
ClarkN. C.,
HillB. C.,
TenoverF. C. Characterization of an Enterococcus raffinosus isolate with a VanB phenotype and vanA genotype. Program and Abstracts of the 94th ASM General Meeting1994 A-111
HaydenM. K.,
PickenR. N.,
SahmD. F. Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanB. Antimicrob Agents Chemother1997; 41:872–874
HaydenM. K.,
TrenholmeG. M.,
SchultzJ. E.,
SahmD. F. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis1993; 167:1224–1227
SahmD. F.,
FreeL.,
HandwergerS. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob Agents Chemother1995; 39:1480–1484
QuintilianiR.,
CourvalinP. Characterization of Tn1547, a composite transposon flanked by IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene1996; 172:1–8
Brisson-NoelA.,
Dutka-MalenS.,
MolinasC.,
LeclercqR.,
CourvalinP. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother1990; 34:924–927
NobleW. C.,
ViraniZ.,
CreeR. G. A. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett1992; 93:195–198
GoldsteinF. W.,
Buu-HoiA. Y.,
WilliamsonR.,
AcarJ. F. A vancomycin-resistant Enterococcus faecium susceptible to teichomycin. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy1987; 275: Abstract 1022
WilliamsonR.,
Al-ObeidS.,
ShlaesJ. H.,
GoldsteinF. W.,
ShlaesD. M. Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis1989; 159:1095–1104
WoodfordN.,
JohnsonA. P.,
MorrisonD.,
ChinA. T. L.,
StephensonJ. R.,
GeorgeR. C. Two distinct forms of vancomycin resistance amongst enterococci in the UK. Lancet1990; 335:226
QuintilianiR.,
EversS.,
CourvalinP. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis1993; 167:1220–1223
PoyartC.,
PierreC.,
QuesneG.,
PronB.,
BercheP.,
Trieu-CuotP. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother1997; 41:24–29
SnellJ. J. S.,
BrownD. F. J.,
PerryS. F.,
GeorgeR. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. J Antimicrob Chemother1993; 32:401–411
RosenbergJ.,
TenoverF. C.,
WongJ.,
JarvisW.,
VugiaD. J. Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?. J Clin Microbiol1997; 35:2526–2530
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd edn. Approved Standard M7-A3 Villanova P. A.: National Committee for Clinical Laboratory Standards; 1993
WoodfordN.,
JonesB. L.,
BaccusZ.,
LudlamH. A.,
BrownD. F. J. Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis. J Antimicrob Chemother1995; 35:179–184
WoodfordN.,
MorrisonD.,
JohnsonA. P.,
BriantV.,
GeorgeR. C.,
CooksonB. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol1993; 31:653–658
Dutka-MalenS.,
EversS.,
CourvalinP. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol1995; 33:24–27
Dutka-MalenS.,
EversS.,
CourvalinP. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR (Erratum). J Clin Microbiol1995; 33:1434
WoodfordN.,
EgeltonC. M.,
MorrisonD. Comparison of PCR with phenotypic methods for the speciation of enterococci. In
HoraudT.,
BouvetA.,
LeclercqR.,
de MontclosH.,
SicardM.
(eds) Streptococci and the host (Advances in experimental medicine and biology, vol 418.) New York: Plenum Publishing Corporation; 1997405–408
AllenN. E.,
HobbsJ. N.,
RichardsonJ. M.,
RigginR. M. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol Lett1992; 98:109–115
ArthurM.,
MolinasC.,
BuggT. D. H.,
WrightG. D.,
WalshC. T.,
CourvalinP. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother1992; 36:867–869
ReynoldsP. E.,
SnaithH. A.,
MaguireA. J.,
Dutka-MalenS.,
CourvalinP. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174. Biochem J1994; 301:5–8
BuggT. D. H.,
Dutka-MalenS.,
ArthurM.,
CourvalinP.,
WalshC. T. Identification of vancomycin resistance protein VanA as a d-alanine: d-alanine ligase of altered substrate specificity. Biochemistry1991; 30:2017–2021
EversS.,
ReynoldsP. E.,
CourvalinP. Sequence of the vanB and ddl genes encoding D-alanine: D-lactate and D-alanine: D-alanine ligases in vancomycin-resistant Enterococcus faecalis V583. Gene1994; 140:97–102
EversS.,
SahmD. F.,
CourvalinP. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala: D-Ala ligases and glycopeptide-resistance proteins VanA and VanC. Gene1993; 124:143–144
Dutka-MalenS.,
MolinasC.,
ArthurM.,
CourvalinP. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene1992; 112:53–58
HandwergerS.,
SkobleJ. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother1995; 39:2446–2453
QuintilianiR.,
CourvalinP. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol Lett1994; 119:359–364
ArthurM.,
MolinasC.,
Dutka-MalenS.,
CourvalinP. Structural relationship between the vancomycin resistance protein VanH and 2-hydroxycarboxylic acid dehydrogenases. Gene1991; 103:133–134
BuggT. D. H.,
WrightG. D.,
Dutka-MalenS.,
ArthurM.,
CourvalinP.,
WalshC. T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry1991; 30:10408–10415
EversS.,
CourvalinP. Regulation of VanB-type vancomycin resistance gene expression by the VanSB-VanRB two-component regulatory system in Enterococcus faecalis V583. J Bacteriol1996; 178:1302–1309
ReynoldsP. E.,
DepardieuF.,
Dutka-MalenS.,
ArthurM.,
CourvalinP. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol Microbiol1994; 13:1065–1070
WrightG. D.,
MolinasC.,
ArthurM.,
CourvalinP.,
WalshC. T. Characterization of VanY, a DD-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob Agents Chemother1992; 36:1514–1518
ArthurM.,
DepardieuF.,
SnaithH. A.,
ReynoldsP. E.,
CourvalinP. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors. Antimicrob Agents Chemother1994; 38:1899–1903
ArthurM.,
DepardieuF.,
MolinasC.,
ReynoldsP.,
CourvalinP. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene1995; 154:87–92
NicasT. I.,
WuC. Y. E.,
HobbsJ. N.,
PrestonD. A.,
AllenN. E. Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Che-mother1989; 33:1121–1124
HolmanT. R.,
WuZ.,
WannerB. L.,
WalshC. T. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. Biochemistry1994; 33:4625–4631
ArthurM.,
DepardieuF.,
GerbaudG.,
GalimandM.,
LeclercqR.,
CourvalinP. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes in Tn1546 and related elements in the absence of induction. J Bacteriol1997; 179:97–106
HandwergerS.,
DiscottoL.,
ThanassiJ.,
PucciM. J. Insertional inactivation of a gene which controls expression of vancomycin resistance on plasmid pHKK100. FEMS Microbiol Lett1992; 92:11–14
BaptistaM.,
DepardieuF.,
ReynoldsP.,
CourvalinP.,
ArthurM. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol1997; 25:93–105
FraimowH. S.,
JungkindD. L.,
LanderD. W.,
DelsoD. R.,
DeanJ. L. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med1994; 121:22–26
RosatoA.,
PierreJ.,
Billot-KleinD.,
Buu-HoiA.,
GutmannL. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother1995; 39:830–833
AslangulE.,
BaptistaM.,
FantinB. Selection of glycopeptide-resistant mutants of Van-B-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. J Infect Dis1997; 175:598–605
SifaouiF.,
GutmannL. Vancomycin dependence in a VanA-producing Enterococcus avium strain with a nonsense mutation in the natural d-Ala-d-Ala ligase gene. Antimicrob Agents Chemother1997; 41:1409
MorrisonD.,
CookeR. P. D.,
KaufmannM. E.,
CooksonB. D.,
StephensonJ. Inter-hospital spread of vancomycin-resistant Enterococcus faecium. J Hosp Infect1997; 36:77–78
ChadwickP. R.,
OppenheimB. A.,
FoxA.,
WoodfordN.,
MorgensternG. R.,
ScarffeJ. H. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect1996; 34:171–182
JohnsonA. P.,
UttleyA. H. C.,
WoodfordN.,
GeorgeR. C. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev1990; 3:280–291
ChowJ. W.,
KuritzaA.,
ShlaesD. M.,
GreenM.,
SahmD. F.,
ZervosM. J. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol1993; 31:1609–1611
BatesJ.,
JordensJ. Z.,
GriffithsD. T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother1994; 34:507–514
AarestrupF. M. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist1995; 1:255–257
KlareI.,
HeierH.,
ClausH.Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist1995; 1:265–272
AarestrupF. M.,
AhrensP.,
MadsenM.,
PallesenL. Y.,
PoulsenR. L.,
WesthH. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother1996; 40:1938–1940
ChadwickP. R.,
WoodfordN.,
KaczmarskiE. B.,
GrayS.,
BarrellR. A.,
OppenheimB. A. Glycopeptide-resistant enterococci from uncooked meat. J Antimicrob Chemother1996; 38:908–909
Van der AuweraP.,
PensartN.,
KortenV.,
MurrayB. E.,
LeclercqR. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis1996; 173:1129–1136
CoqueT. M.,
TomaykoJ. F.,
RickeS. C.,
OkhyusenP. C.,
MurrayB. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother1996; 40:2605–2609
BagerF.,
MadsenM.,
ChristensenJ.,
AarestrupF. M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med1997; 31:95–112
McDonaldL. C.,
KuehnertM. J.,
TenoverF. C.,
JarvisW. R. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis1997; 3:311–317
MieleA.,
BanderaM.,
GoldsteinB. P. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates. Antimicrob Agents Chemother1995; 39:1772–1778
JensenL. B.,
AhrensP.,
DonsL.,
JonesmR. N.,
HammerumA. M.,
AarestrupF. M. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol1998 (in press)
WoodfordN.,
AdebiyiA. A.,
PalepouM. I.,
CooksonB. D. Diversity of VanA glycopeptide resistance elements in enterococci from human and non-human sources. Antimicrob Agents Chemother1998; 42:502–508
HandwergerS.,
SkobleJ.,
DiscottoL. F.,
PucciM. J. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the Northeastern United States. Antimicrob Agents Chemother1995; 39:362–368
MackinnonM. G.,
DrebotM. A.,
TyrellG. J. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain. Antimicrob Agents Chemother1997; 41:1805–1807
WoodfordN.,
WatsonA. P.,
ChadwickP. R. Investigation by long PCR of the genetic elements mediating VanA glycopeptide resistance in enterococci from uncooked meat in South Manchester. In
HoraudT.,
BouvetA.,
LeclercqR.,
de MontclosH.,
SicarM.
(eds) Streptococci and the host Plenum, (Advances in experimental medicine and biology, vol 418.) New York: 1997409–412
WoodfordN.,
StigterJ. M. Molecular investigation of glycopeptide resistance in gram-positive bacteria. In
WoodfordN.,
JohnsonA. P.
(eds) Molecular bacteriology: protocols and clinical applications Humana Press; Totowa, NJ: 1998579–615
Dutka-MalenS.,
MolinasC.,
ArthurM.,
CourvalinP. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet1990; 224:364–372
Billot-KleinD.,
GutmannL.,
SableS.,
GuittetE.,
van HeijenoortJ. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus faecium D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pento-saceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol1994; 176:2398–2405
HandwergerS.,
PucciM. J.,
VolkK. J.,
LiuJ.,
LeeM. S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J Bacteriol1994; 176:260–264
EversS.,
CasadewallB.,
CharlesM.,
Dutka-MalenS.,
GalimandM. Courvalin P. Evolution of structure and substrate specificity in D-alanine: D-alanine ligases and related enzymes. J Mol Evol1996; 42:706–712
MarshallC. G.,
BroadheadG.,
LeskiwB. K.,
WrightG. D. d-Ala-d-ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc Natl Acad Sci USA1997; 94:6480–6483
MoelleringR. C. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother1991; 28:1–12
FantinB.,
LeclercqR.,
ArthurM.,
DuvalJ.,
CarbonC. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother1991; 35:1570–1575
Boyle-VavraS.,
de JongeB. L. M.,
EbertC. C.,
DaumR. S. Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate. J Bacteriol1997; 179:6756–6763